tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL

Ocular Therapeutix (OCUL) Similar Stocks

Compare
1,498 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ocular Therapeutix
$14.17
$3.10B
-9.86
57.80%
10 Buy
0 Hold
0 Sell
Strong Buy
89bio
$14.84
87.85%
Beam Therapeutics
$27.36
$2.78B
-6.05
-7.26%
11 Buy
2 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$80.48
$3.45B
-39.97
55.58%
6 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$10.24
$1.01B
-13.07
-10.86%
4 Buy
0 Hold
0 Sell
Strong Buy
Belite Bio, Inc. ADR
$141.32
$4.93B
-74.24
125.88%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCUL
Ocular Therapeutix
14.17
5.19
57.80%
ETNB
89bio
14.84
6.94
87.85%
BEAM
Beam Therapeutics
26.83
-2.10
-7.26%
TARS
Tarsus Pharmaceuticals
80.48
28.75
55.58%
SPRY
ARS Pharmaceuticals
10.59
-1.29
-10.86%
BLTE
Belite Bio, Inc. ADR
142.53
79.43
125.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts